Month: May 2021

Founder of Fern Counselling Louise Allen joins Happiful’s podcast to talk about outdoor therapy, how working with nature can be so beneficial, the role of Death Cafes and connecting to nature wherever you are Nature has played such a huge role in our collective wellbeing since the pandemic began. When our usual routines and life
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. In the wake of the COVID-19 pandemic, a population of patients has arisen with a range of symptoms and complications after surviving the acute phase of illness, according to Mezgebe Berhe, MD, of Baylor University Medical Center, Dallas. Different terms have
0 Comments
Journalist, award-winning writer, and competitive amateur powerlifter Poorna Bell shares her own journey to ‘strong’, and why it’s so important to embrace gratitude and abundance when they appear in your life What does the concept of strong mean to you? Is it being able to easily move furniture, lift weights, run a marathon, stay on
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. In a surprising study from the Amazon rainforest, Brazilian scientists found that symptomatic COVID-19 infections were twice as likely to occur in people who had prior dengue. The study, led by Marcelo Urbano Ferreira, MD, PhD, of Brazil’s University of São
0 Comments
At one year, improvements in fatigue were sustained among those treated with mirikizumab Three separate analyses of real-world data highlight the burden of fatigue and rectal urgency among people living with ulcerative colitis or Crohn’s disease INDIANAPOLIS, May 22, 2021 /PRNewswire/ — In a pre-specified analysis of the Phase 2 SERENITY study, Eli Lilly and
0 Comments
Treatment for Agitation Associated with Schizophrenia and Bipolar Disorders BioXcel Therapeutics Announces FDA Acceptance for Filing of NDA for BXCL501 for the Acute Treatment of Agitation Associated with Schizophrenia and Bipolar Disorders I and II NEW HAVEN, Conn., May 19, 2021 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage
0 Comments
In this article PFE 22UA-DE AZN-GB PEAK A healthcare worker holds syringes with the Moderna and Pfizer vaccines against the coronavirus disease (COVID-19) at a vaccination centre, in El Paso, Texas, May 6, 2021. Jose Luis Gonzalez | Reuters A new study has found that two doses of either the Pfizer-BioNTech or AstraZeneca-University of Oxford
0 Comments
While the earlier waves of the coronavirus disease 2019 (COVID-19) pandemic relatively spared children, some of the affected children have developed a systemic inflammatory condition, with occasionally fatal outcomes. Called multisystem inflammatory syndrome in children (MIS-C), its pathogenesis and risk factors are the subject of a new study on the medRxiv* preprint server. MIS-C MIS-C
0 Comments
Note that some links may require registration or subscription. In November 2019, three researchers from Wuhan’s Institute of Virology were all sick enough to seek hospital care for symptoms consistent with COVID-19 or seasonal illness, adding fuel to the “lab leak” theory. (Wall Street Journal) CDC is investigating a handful of myocarditis cases following COVID-19
0 Comments
3,000 to 4,000 cancer deaths a year could be prevented by lung cancer CT screening programmes, beyond current lung health checks, writes Professor Charles Swanton. Credit: Wikimedia Commons/CC BY-SA 2.0 Comment and opinion from Cancer Research UK’s community of experts. The opinions outlined in this article do not necessarily represent the views of Cancer Research
0 Comments
Researchers examining GI endoscopes after colonoscopy and esophagogastroduodenoscopy (EGD) procedures found a “startingly high” rate of retained biopsy samples in the endoscope accessory channel or cap. Investigators found 64% of 105 total endoscopies featured retained biopsy samples, including 76% of EGDs and 50% of colonoscopies examined. “The take-home message would be that retained biopsies are
0 Comments
COVID-19 vaccines are the most effective way to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. For people who are already infected, new research suggests the small molecule stimulator of interferon genes (STING) agonist-1, diABZI, may be effective in controlling SARS-CoV-2 infection — including those caused by variants. Led by Sara Cherry from the
0 Comments
In this article WBA Theranos founder Elizabeth Holmes leaves the Robert F. Peckham Federal Building with her defense team in downtown San Jose, Calif., on Tuesday, May 4, 2021. MediaNews Group/The Mercury News via Getty Images | MediaNews Group | Getty Images Money may buy happiness but in the case of former Theranos CEO Elizabeth
0 Comments
Yvette Taylor, creator of the Energy Alignment Method, shares nine affirmations and release statements to make the most of our spiritual practice Do you ever dream of a day when your spiritual practices work out? When all the affirmations, visualisation, journaling, drumming, tapping, praying and shouting out loud, finally turn into your everyday reality? The
0 Comments
A ‘smart toilet’ in development uses artificial intelligence (AI) to scan stool for consistency and presence of blood — and early evidence suggests it is more accurate than patient self-reporting, a study reveals. The remote, automated, real-time analysis and reporting increase the likelihood of physicians detecting gastrointestinal (GI) issues earlier, investigators report. In a proof-of-concept
0 Comments
Patients with refractory out-of-hospital cardiac arrest (OHCA) receiving “hyperinvasive” rather than standard care had better overall outcomes, researchers in the randomized Prague OHCA trial conclude. The primary endpoint, survival at 180 days with a favorable neurologic outcome, defined as a cerebral performance category (CPC) score of 1 or 2, was numerically higher with the hyperinvasive
0 Comments
May 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated data from the Phase 1 CHRYSALIS study showing treatment with amivantamab in combination with lazertinib led to a median duration of response (DOR) of 9.6 months in chemotherapy-naïve patients with non-small cell lung cancer (NSCLC) and epidermal growth factor
0 Comments
FDA Approves Rybrevant (amivantamab-vmjw) as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations May 21, 2021 (HORSHAM, P.A.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the accelerated approval of Rybrevant (amivantamab-vmjw) for the
0 Comments